NasdaqCM - Nasdaq Real Time Price USD

China SXT Pharmaceuticals, Inc. (SXTC)

4.5300 -1.9350 (-29.93%)
At close: February 3 at 4:00:01 PM EST
4.8900 +0.3600 (+7.95%)
Overnight: 8:21:34 PM EST
Reverse stock split
SXTC announces 1 for 150 split effective Feb. 3, 2026
Chart Range Bar
Loading chart for SXTC
Chart does not reflect overnight price.
  • Previous Close 6.4650
  • Open 5.6000
  • Bid 5.0100 x 100
  • Ask 0.0416 x 300
  • Day's Range 4.3000 - 6.4000
  • 52 Week Range 4.0050 - 1,176.0000
  • Volume 348,369
  • Avg. Volume 160,841
  • Market Cap (intraday) 3.866M
  • Beta (5Y Monthly) 1.68
  • PE Ratio (TTM) --
  • EPS (TTM) -57.1500
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, and raw medicinal material, such as SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, ShaRen, and ChenXiang. It provides its products under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands. The company serves pharmaceutical companies, chain pharmacies, and hospitals, as well as pharmaceutical distributors. China SXT Pharmaceuticals, Inc. was incorporated in 2005 and is headquartered in Taizhou, China.

www.sxtchina.com

75

Full Time Employees

March 31

Fiscal Year Ends

Performance Overview: SXTC

Trailing total returns as of 2/3/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

SXTC
183.13%
S&P 500 (^GSPC)
1.06%

1-Year Return

SXTC
1,043.94%
S&P 500 (^GSPC)
15.40%

3-Year Return

SXTC
69.29%
S&P 500 (^GSPC)
67.24%

5-Year Return

SXTC
93.73%
S&P 500 (^GSPC)
80.61%

Statistics: SXTC

View More

Valuation Measures

Annual
As of 2/2/2026
  • Market Cap

    5.52M

  • Enterprise Value

    -14.45M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.66

  • Price/Book (mrq)

    0.27

  • Enterprise Value/Revenue

    100.14

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -18.27%

  • Return on Equity (ttm)

    -50.30%

  • Revenue (ttm)

    1.54M

  • Net Income Avi to Common (ttm)

    -8.87M

  • Diluted EPS (ttm)

    -57.1500

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    21.31M

  • Total Debt/Equity (mrq)

    5.95%

  • Levered Free Cash Flow (ttm)

    -1.95M

Compare To: SXTC

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Company Insights: SXTC

Fair Value

4.5300 Current
 

Dividend Score

0 Low
Sector Avg.
100 High
 

Hiring Score

0 Low
Sector Avg.
100 High
 

Insider Sentiment Score

0 Low
Sector Avg.
100 High
 

People Also Watch